United Therapeutics Corp (NASDAQ:UTHR)

CAPS Rating: 4 out of 5

A biotechnology company focused on the development and commercialization of innovative therapeutic products for patients with chronic and life-threatening cardiovascular, cancer and infectious diseases.

Recs

0
Player Avatar kevrose31 (57.46) Submitted: 11/3/2007 5:52:34 PM : Outperform Start Price: $52.42 UTHR Score: -8.46

Wow.

Featured Broker Partners


Advertisement